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M A J O R A R T I C L E
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Infections
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Joseph Horwinski,2 Stephen Porter,4 Marc Stegger,2,5 James R. Johnson,4,6 Cindy M. Liu,2,7 and Lance B. Price1,2
1George Washington University Milken Institute School of Public Health, Washington D.C.; 2Translational Genomics Research Institute, and 3Flagstaff
Medical Center, Arizona; 4VA Healthcare System Minneapolis, Minnesota; 5Statens Serum Institut, Copenhagen, Denmark; 6Department of Medicine,
University of Minnesota, Minneapolis; and 7Johns Hopkins School of Medicine, Baltimore, Maryland
Background. Klebsiella pneumoniae is a common colonizer of the gastrointestinal tract of humans, companion
animals, and livestock. To better understand potential contributions of foodborne K. pneumoniae to human clinical
infections, we compared K. pneumoniae isolates from retail meat products and human clinical specimens to assess
their similarity based on antibiotic resistance, genetic relatedness, and virulence.
Methods. Klebsiella pneumoniae was isolated from retail meats from Flagstaff grocery stores in 2012 and from
urine and blood specimens from Flagstaff Medical Center in 2011–2012. Isolates underwent antibiotic susceptibility
testing and whole-genome sequencing. Genetic relatedness of the isolates was assessed using multilocus sequence
typing and phylogenetic analyses. Extraintestinal virulence of several closely related meat-source and urine isolates
was assessed using a murine sepsis model.
Results. Meat-source isolates were significantly more likely to be multidrug resistant and resistant to tetracycline
and gentamicin than clinical isolates. Four sequence types occurred among both meat-source and clinical isolates.
Phylogenetic analyses confirmed close relationships among meat-source and clinical isolates. Isolates from both
sources showed similar virulence in the mouse sepsis model.
Conclusions. Meat-source K. pneumoniae isolates were more likely than clinical isolates to be antibiotic resistant,
which could reflect selective pressures from antibiotic use in food-animal production. The close genetic relatedness
of meat-source and clinical isolates, coupled with similarities in virulence, suggest that the barriers to transmission
between these 2 sources are low. Taken together, our results suggest that retail meat is a potential vehicle for trans-
mitting virulent, antibiotic-resistant K. pneumoniae from food animals to humans.
Keywords. food; meat; poultry; antibiotic resistance; Klebsiella.
Classic foodborne bacterial pathogens, such as Listeria
monocytogenes, Salmonella enterica, Campylobacter
species, and diarrheagenic Escherichia coli, have driven
most food-safety science and policy to date [1].
However, the bacterial species that contaminate meat
products extend well beyond these “usual suspects”
[2–5]. Today, it is increasingly recognized that coloniz-
ing opportunistic pathogens such as extraintestinal
pathogenic E. coli, Enterococcus species, and Clostridi-
um difficile may also be transmitted from food animals
to humans via retail meat [2, 3, 6–9]. Furthermore, an-
tibiotic resistance has been increasing among Entero-
bacteriaceae that contaminate retail meats, particularly
poultry products [10]. Thus, there is a continued need
to characterize more fully the breadth and public health
relevance of bacterial pathogens in our food supply.
Klebsiella pneumoniae is a colonizing opportunistic
pathogen of humans and animals, and a common con-
taminant of retail meat [4]. In animals, K. pneumoniae
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causes disease in cows, horses, and companion animals [11, 12].
In humans, K. pneumoniae frequently colonizes the gut and
sporadically causes extraintestinal infections [13]. Although
named for its capacity to cause pneumonia, K. pneumoniae
also causes a wide range of other infections, including cystitis,
pyelonephritis, osteomyelitis, meningitis, bacteremia, septicemia,
liver abscess, and wound infections [13–15]. Additionally,
increasing multidrug resistance among K. pneumoniae strains
makes the clinical management of these infections more chal-
lenging [16–18]. The notoriety of K. pneumoniae as a multi-
drug-resistant pathogen can be attributed, in part, to successful
lineages such as the carbapenem-resistant K. pneumoniae se-
quence type (ST) 258 [19]. However, broader analysis shows
that the total K. pneumoniae population causing antibiotic-resis-
tant infections in humans is genetically diverse [20, 21]. Thus, it
is essential to characterize the origins and epidemiology of both
epidemic and sporadic K. pneumoniae strains, of which meat
may be an important reservoir.
To better understand the potential contribution of foodborne
K. pneumoniae to human infections, we assessed the phenotyp-
ic and phylogenetic similarity of contemporaneously collected
meat-source and clinical K. pneumoniae isolates. We compared
the 2 populations using whole-genome sequence (WGS)–based
phylogenetic analysis and in vivo virulence models.
MATERIALS AND METHODS
Sequence Data Accession Numbers
The sequences generated from the 82 isolates described in this
study are available in the NCBI short read archive (SRA) under
the accession number SRP060821.
Meat Sample Collection and Processing
Retail turkey, chicken, and pork products were purchased from
all 9 major grocery store chains (1 store per chain) in Flagstaff,
Arizona, from January to October 2012. No bodegas (conve-
nience stores) were sampled. Retail meat samples were pur-
chased as part of a larger study focusing on extraintestinal
pathogenic E. coli (ExPEC). Beef was not included due to the
low prevalence of ExPEC in these products [3, 22].
Samples were processed no later than 1 day past the sell-by
date. From each package, 1 whole piece of meat, or 325 g ±
10% of ground products, was transferred aseptically to a Stom-
acher bag (VWR, Radnor, Pennsylvania) containing 250 mL
MacConkey broth (Alpha Biosciences, Baltimore, Maryland).
(For the first five collections 30 g ± 10% of each ground sample
was used during processing). After overnight enrichment at 44°
C, a violet red bile agar plus 4-methylumbelliferyl-ß-D-glucuro-
nide (VRBA +MUG) (Teknova, Hollister, California) plate
was inoculated with 10 µL of broth and incubated at 37°C
for 2 hours and then at 44°C for 22 hours. Four putative
K. pneumoniae colonies from each VRBA +MUG plate were
streaked onto CHROMagar (Hardy Diagnostics, Santa Maria,
California) and incubated for 20–24 hours at 37°C. Finally, 1
putative K. pneumoniae colony, appearing blue in color on
CHROMagar, was streaked for isolation on a second CHROMa-
gar plate and incubated for 20–24 hours at 37°C. Isolates were
confirmed as K. pneumoniae by DNA sequence analysis and
stored at −80°C in Brucella broth with 20% glycerol.
Clinical K. pneumoniae Isolates
Klebsiella pneumoniae clinical isolates were collected from all
routinely submitted clinical urine or blood specimens processed
by the Flagstaff Medical Center from November 2011 to October
2012 in Flagstaff, Arizona, without regard for patient character-
istics or clinical context. The Flagstaff Medical Center is the only
hospital in Flagstaff, and its clinical laboratory serves healthcare
centers throughout northern Arizona, except for certain outpa-
tient clinics that utilize third-party diagnostic laboratories. The
Northern Arizona Healthcare Institutional Review Board ap-
proved this study. Awaiver of consent and Health Insurance Por-
tability and Accountability Act authorization were obtained.
Phenotypic Susceptibility Testing
The antibiotic susceptibility profile of each isolate was determined
by the disk diffusionmethod according to Clinical and Laboratory
Standards Institute (CLSI) guidelines [23]. The antibiotics tested
were as follows: amikacin, ampicillin, ampicillin-sulbactam, cefa-
zolin, cefoxitin, ceftriaxone, ceftazidime, cefotaxime, ciprofloxa-
cin, gentamicin, imipenem, nalidixic acid, tetracycline, and
trimethoprim-sulfamethoxazole. Isolates were classified as “sus-
ceptible,” “intermediate,” or “resistant” in accordance with 2011
breakpoint guidelines from the CLSI [23]. For statistical analyses,
“intermediate” and “resistant” isolates were grouped together.
The antibiotics represented 7 different classes: aminoglyco-
sides (amikacin and gentamicin), carbapenems (imipenem),
cephalosporins (cefazolin, cefoxitin, ceftriaxone, ceftazidime,
and cefotaxime), folate pathway inhibitors (trimethoprim-
sulfamethoxazole), penicillins and penicillin combinations
(ampicillin and ampicillin-sulbactam), quinolones (nalidixic
acid and ciprofloxacin), and tetracyclines (tetracycline). Klebsi-
ella pneumoniae is intrinsically resistant to ampicillin; therefore,
isolates were categorized as multidrug resistant if they were re-
sistant to ≥2 additional antibiotic classes (ie, ≥3 classes total).
Extended-Spectrum β-Lactamase Confirmatory Test
Extended-spectrum β-lactamase (ESBL) phenotype was assessed
by a standard disk diffusion method involving 30 µg cefotaxime
and 30 µg ceftazidime disks, each with and without 10 µg supple-
mental clavulanic acid (BD Diagnostic Systems, Sparks, Mary-
land). Isolates with a zone of inhibition ≥5 mm larger for
either drug in combination with clavulanic acid vs the zone di-
ameter for the drug alone were defined as ESBL producers [23].













For each isolate, 1–5 µg DNA in 200 µL was sheared to a size
range of 200–1000 bp with the SonicMAN sonicator (Matrical
BioScience, Spokane, Washington) and then purified using the
Qiagen QIAquick polymerase chain reaction (PCR) Purifica-
tion kit (Qiagen, Valencia, California). Enzymatic processing
of the DNAwas performed according to Illumina’s recommen-
dations using enzymes obtained from New England Biolabs
(New England Biolabs, Ipswich, Massachusetts) and Illumina
(Illumina, Inc, San Diego, California) oligonucleotides and
adaptors.
After ligation of the adaptors, the DNAwas separated electro-
phoretically on a 2% agarose gel for 2 hours, after which a gel
slice containing 500- to 600-bp fragments of each DNA sample
was isolated and then purified using the Qiagen QIAquick Gel
Extraction kit (Qiagen). Individual libraries were quantified by
quantitative PCR using a Kapa Library Quantification kit (Kapa
Biosystems, Woburn, Massachusetts). Equimolar pools of ≤12
indexed E. coli libraries were prepared at a concentration of
≥1 nM using 10mM Tris-HCl (pH 8.0) with 0.05% Tween
20. The pooled paired-end libraries were sequenced on an Illu-
mina Genome Analyzer IIx to a read length of at least 76 bp.
Muiltilocus Sequence Typing
In silico multilocus sequence typing (MLST) was done accord-
ing to the scheme of Diancourt et al, which uses allelic variation
at 7 housekeeping gene loci to assign STs [20]. Alleles were
assigned to each isolate using the WGS data in the computer
program short read sequence typing for bacterial pathogens
[24]. Novel alleles were subjected to Sanger sequencing at ID
Genomics (http://idgenomics.com) and were submitted to the
Institut Pasteur’s K. pneumoniae MLST database (http://
bigsdb.web.pasteur.fr/klebsiella/klebsiella.html).
Single-Nucleotide Polymorphism Identification
Illumina WGS data sets were aligned against the K. pneumoniae
strain MGH78578 chromosome (GenBank accession number
CP000647) using the short-read alignment component of the
Burrows-Wheeler aligner. Each alignment was analyzed for
single-nucleotide polymorphisms (SNPs) using the genome
analysis tool kit software [25]. Prior to calling SNPs, we em-
ployed a stringent downstream pipeline that filtered out low-
quality reads. In brief, we employed the following steps: verified
that sequencing reads were of the expected length (100 bp), that
the percentage of ≥Q30 bases was >80%, and that the mean
Phred quality score of each sample was approximately 30. SNP
loci were excluded if they did not meet a minimum coverage of
10× and if the variant was present in <90% of the base calls for
that position. To be included in the final SNP matrix, the locus
had to be present in all of the genomes. SNPs from duplicated or
repetitive regions on the reference genome were discarded.
Whole-Genome Phylogenetic Analyses
The inferred phylogeny was estimated with FastTree2 software,
version 2.1.8 [26], using a general time-reversible model of
DNA sequence evolution. Escherichia coliNA114 (GenBank ac-
cession number CP002797) [27] was used as an outgroup to
root the K. pneumoniae WGS tree. Klebsiella pneumoniae iso-
lates in the clade closest to this bifurcation point were used to
root the final tree.
In Vivo Virulence Model
Five pairs of genetically similar meat-source and clinical isolates
were selected to determine their virulence in a mouse model of
subcutaneous sepsis that measures both illness severity and le-
thality [28]. Each isolate was tested in 10 mice, 5 of which
received a low-dose inoculum (1.5 × 108–3.3 × 108 colony-form-
ing units [CFU]/mL) and 5 a high-dose inoculum (8.0 × 108–
1.4 × 109 CFU/mL). Mice were injected with log-phase organ-
isms and then observed for health status twice daily for the fol-
lowing 3 days. Maximal illness severity was scored daily on a 5-
point scale, where 1 = no illness and 5 = death. The infection ex-
perience of each mouse during the observation period was sum-
marized as the mean of the daily illness severity scores.
Statistical Analyses
For categorical data, statistical significance was assessed with 2-
tailed Fisher exact tests. Extent of resistance was assessed by
comparing groups of isolates according to the number of anti-
biotics, and antibiotic classes to which each isolate was resistant,
using the Kruskal–Wallis test. Virulence was assessed by com-
paring mean mouse illness severity scores between groups of
isolates, again using the Kruskal–Wallis test. Central tendencies
were expressed as group medians (range). Statistical analyses
were implemented in R version 3.0.1 [29]. The threshold for
statistical significance was α = .05.
RESULTS
Study Isolates
During the collection period, K. pneumoniae accounted for 174
of the 1728 (10%) human clinical isolates obtained from the Flag-
staff Medical Center. Concurrently, K. pneumoniaewas recovered
from 241 of the 508 (47%) locally purchased retail meat products.
Meat product contamination varied significantly in prevalence by
meat type, along a gradient as follows: 58% (65/112) for pork,
47% (128/272) for chicken, and 38% (48/128) for turkey (for tur-
key vs pork, P = .003; for turkey vs chicken, P = .02).
A subset of 82 K. pneumoniae isolates was randomly chosen
for WGS, including 38 clinical and 44 meat-source isolates,
to give approximately equal numbers per meat type. Among
the clinical isolates, 20 qualified as community-acquired, 4 as
hospital-acquired, and 6 as healthcare-acquired, whereas 8












lacked data regarding acquisition source. The 44 meat-source
isolates were recovered from chicken (n = 16), turkey (n = 17),
and pork (n = 11) (Supplementary Table 1).
Antibiotic Susceptibility
As expected for Klebsiella, resistance to ampicillin was nearly
ubiquitous (1 clinical isolate was susceptible). In contrast, no re-
sistance was detected to amikacin or imipenem. For the remain-
ing antibiotics, resistance prevalence varied by antimicrobial
agent and by isolate source (Figure 1). Resistance prevalence
was greater among meat-source isolates for all antibiotics except
trimethoprim-sulfamethoxazole and nalidixic acid, and signifi-
cantly so for tetracycline (P = .001) and gentamicin (P = .029).
Among the clinical isolates, antimicrobial resistance prevalence
did not vary by acquisition source (ie, community, healthcare,
or hospital). Among the meat-source isolates, those from turkey
displayed the greatest resistance prevalence to all antibiotics
tested except for cefoxitin, for which resistance was most prev-
alent among pork isolates. Resistance prevalence differences by
meat type were significant for ampicillin-sulbactam (P = .007),
cefazolin (P = .004), and tetracycline (P < 0.001) (Supplementa-
ry Figure 1). ESBL production was confirmed phenotypically in
2 isolates, both from poultry (1 each from chicken and turkey).
Approximately 22% of isolates overall were multidrug resistant,
including 32% of meat-source isolates but only 8% of clinical
isolates (P = .014). Compared with human isolates, meat-source
isolates were resistant to significantly more individual antibiotics
(median, 1 [range, 1–9] vs 1 [range, 0–5]; P = .038) and more an-
tibiotic classes (median, 1 [range, 1–5] vs 1 [range, 0–4]; P = .043).
Multilocus Sequence Typing
Overall, 60 STs were identified (Supplementary Table 1), 21
(35%) of which were novel. Four STs (ST14, ST76, ST111,
and ST188) included both meat-source and clinical isolates
(Supplementary Figure 2). The ST188 isolates had heteroge-
neous susceptibility profiles, whereas the clinical and meat-
source ST14, ST76, and ST111 isolates were susceptible to all
antibiotics except ampicillin.
Phylogenetic Analyses
Phylogenetic analysis based on core SNPs identified 2 distinct
clades, each containing both meat-source and clinical isolates
(Figure 2). The smaller clade was well resolved and corresponds
to K. pneumoniae phylogroup III (a.k.a., Klebsiella variicola)
[30, 31]. The larger clade, corresponding to K. pneumoniae phy-
logroup I [30], appeared to have undergone a rapid radiation
with subsequent, but varying, degrees of diversification, as evi-
denced by the short internal branches and variable-length ter-
minal branches. Although some subclusters were source
specific, meat-source and clinical isolates were intermingled in
both main clades.
Core-genome phylogenetic analysis showed that there were 5
closely related isolate pairs in which each pair contained 1 clin-
ical and 1 meat-source isolate. Based on MLST, 4 of the isolate
pairs shared identical STs (ST14, ST76, ST111, and ST188),
whereas 1 pair displayed discordant STs (ST17 and ST1123)
(Figure 2). ST1123 and ST17 were single-locus variants that dif-
fered by only 1 SNP in gapA; both isolates were susceptible to all
antibiotics except ampicillin. Thus, of the 38 human clinical
study isolates, 5 (13%) were closely related to meat-source iso-
lates based on core-genome SNP analysis.
In Vivo Virulence Model
These 5 K. pneumoniae isolate pairs, each containing a clinical
isolate and a genomically matched meat-source isolate (Fig-
ure 2), were assessed for virulence using a standard murine sub-
cutaneous sepsis model. In this model, E. coli pyelonephritis
strain CFT073 routinely kills 80%–100% of challenged mice,
Figure 1. Antibiotic resistance prevalence of meat-source vs clinical Klebsiella pneumoniae isolates. The antibiotics tested were as follows: ampicillin
(AMP), ampicillin-sulbactam (SAM), cefazolin (CFZ), cefoxitin (FOX), ceftriaxone (CRO), ceftazidime (CAZ), cefotaxime (CTX), ciprofloxacin (CIP), gentamicin
(GEN), nalidixic acid (NAL), tetracycline (TET), and trimethoprim-sulfamethoxazole (SXT). Multidrug resistance (MDR) was defined as resistance to ≥3 clas-
ses of antibiotics. None of the isolates were resistant to amikacin or imipenem (not shown). *P < .05; **P < .01.












Figure 2. Rooted phylogeny of 83 Klebsiella pneumoniae isolates. The inferred phylogeny was based on 62 437 core single-nucleotide polymorphisms
and rooted with Escherichia coli NA114. Isolates are coded by source (ie, clinical [dark gray] or meat source [light gray]), multilocus sequence type (ST), and
multidrug resistant (MDR [black boxes]). The large upper clade corresponds to K. pneumoniae phylogroup I and the smaller well-resolved clade corresponds
to K. pneumoniae phylogroup III (a.k.a., Klebsiella variicola) [30, 31]. The scale bar reflects genetic distance, reported as the expected number of nucleotide
changes per site. The 5 most closely related meat–human isolate pairs, indicated with boxes, were tested in a murine sepsis model. *Branches leading to
the 2 main clades were manually shortened; the length of each branch is indicated on each branch. **ST1123 and ST17 differ by a single nucleotide.












whereas laboratory strain MG1655 (K-12) causes no discernible
mouse illness. For the 10 K. pneumoniae isolates, with 100 total
mice tested (10 per isolate; 5 each at a high- vs a low-inoculum
dose), the overall median per-isolate mouse illness severity score
was 2 (range, 1–3), with no lethality. Disease severity increased
in a dose-dependent manner for 7 of 10 isolates (3 meat-source,
4 clinical) (Supplementary Table 2).
At the lower challenge dose, 1 of the closely related isolate
pairs showed a significant within-pair difference in virulence
that favored the meat-source isolate (P = .04). At the higher
challenge dose, 2 of 5 isolate pairs exhibited a significant with-
in-pair virulence difference, in 1 instance favoring the meat-
source isolate (P = .02), in the other the clinical isolate
(P = .02). Thus, in a murine sepsis model that was able to detect
significant virulence differences between individual K. pneumo-
niae isolates and different dose levels, meat-source and human
clinical isolates displayed relatively similar levels of virulence,
without overall source group–specific differences (Figure 3).
Figure 3. Virulence of 5 pairs of closely related meat-source and clinical isolates in a murine subcutaneous sepsis model. Isolates were tested at a low
dose (A) and a high dose (B ). Illness severity (mean mouse status) was scored on a 5-point scale where 1 = no illness and 5 = death. Each circle represents
the mean status score for a given mouse (n = 5) over a 3-day observation period. None of the isolates were lethal. *P < .05.













In this study, we assessed 82 K. pneumoniae isolates from retail
meat products and human clinical specimens for phenotypic
and genotypic relatedness. Whereas meat isolates were more ex-
tensively antibiotic resistant, the 2 populations were genetically
intermingled and, for closely related isolates, exhibited similar
virulence in a murine sepsis model.
Antibiotic resistance has been increasing within K. pneumo-
niae [18],with the rapid dissemination of K. pneumoniae carba-
penemases being of particular concern [16, 32]. The human
clinical isolates studied here exhibited varied resistance profiles
(Figure 1), but were generally less extensively resistant than
those reported in other studies of US inpatient and outpatient
populations [18, 33, 34]. Encouragingly, none of the clinical iso-
lates in the current study were resistant to third-generation
cephalosporins or imipenem. These findings may reflect region-
al differences in antibiotic use and dissemination of antibiotic-
resistant K. pneumoniae strains.
Antibiotic resistance, including multidrug resistance, was more
prevalent and extensive among meat-source K. pneumoniae iso-
lates than human clinical isolates. Third-generation cephalospo-
rin resistance—including ESBL production (2 isolates)—was
confined to the meat-source isolates, and resistance to gentamicin
and tetracycline was significantly more prevalent among meat-
source isolates. All of the present meat-source isolates were col-
lected in 2012, during which year >5.9 million kg of tetracyclines
and 273 536 kg of aminoglycosides were sold or distributed for
use in food-animal production in the United States [35]. Thus,
the distinct resistance profiles of the 2K. pneumoniae populations
may reflect antibiotic selective pressures at their source—that is,
food-animal production vs hospital and general community use.
Unfortunately, the US Food and Drug Administration does not
collect detailed data on antibiotic use in food-animal production,
making it difficult to draw direct connections in this or other
studies between antibiotic use and resistance [35].
In contrast to thesephenotypicdifferences, genetic analysesdem-
onstrated overlap between themeat-source and clinicalK. pneumo-
niae populations. Specifically, MLST identified 4 STs and a single-
locus variant pair (ST1123 and ST17) that contained both meat-
source and clinical isolates. High-resolution phylogenetic analysis
confirmed that meat-source and clinical isolates do not represent
distinct populations, but are intermingled across the phylogeny.
Furthermore, closely related meat-source and clinical isolates dis-
played similar, albeit relatively low-level, virulence in amouse sub-
cutaneous sepsis model. Low-level virulence in mouse models has
also been reported for the epidemic ST258 strain, suggesting that
the increased morbidity and mortality associated with this clone
in humans stems more from the clone’s expanded antibiotic resis-
tancerepertoire than fromanyspecial virulence [36].Taken togeth-
er, the closephylogenetic relationshipsandsimilar in vivovirulence
of meat- and clinical-source K. pneumoniae isolates suggests there
maybea lowbarrier to transmissionbetween these2environments.
This study identified a diverse population of antibiotic-
resistant K. pneumoniae from retail meat sources. Although
these isolates did not include some of the most notorious epi-
demic K. pneumoniae clones (eg, ST258), we did identify a tur-
key-source epidemic clone, ST15, that is common in both
humans and companion animals [12]. It is critical to recognize
that although epidemic lineages can be associated with severe
disease and poor clinical outcomes, they account for only a
minor portion of all K. pneumoniae infections, most of which
are due to sporadic clones. Understanding the epidemiology of
these sporadic clones, and their reservoirs and transmission path-
ways, will help elucidate the key drivers of resistance and may
identify opportunities for intervention, both of which are critical
to reducing the overall K. pneumoniae disease burden. Here we
show that retail meat may be an important source of antibiotic-
resistant K. pneumoniae of possible human health significance,
which increases the range of potential public health risks
associated with antibiotic use in food-animal production.
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